Simplex Trading’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22
Closed -$15 10173
2023
Q4
$0 Buy
+22
New +$18 ﹤0.01% 10097
2023
Q3
Sell
-6,811
Closed -$18.8K 10116
2023
Q2
$19K Buy
6,811
+2,160
+46% +$4.89K ﹤0.01% 6851
2023
Q1
$11K Sell
4,651
-2,580
-36% -$7.16K ﹤0.01% 7496
2022
Q4
$13K Buy
7,231
+2,559
+55% +$4K ﹤0.01% 7326
2022
Q3
$5K Buy
4,672
+659
+16% +$1.44K ﹤0.01% 8839
2022
Q2
$9K Sell
4,013
-14,762
-79% -$70.2K ﹤0.01% 8411
2022
Q1
$129K Sell
18,775
-573
-3% -$6.07K ﹤0.01% 5800
2021
Q4
$307K Buy
+19,348
New +$387K ﹤0.01% 4530

Other funds holding RNLX

Simplex Trading's RNLX Position: Q1 2024 in Review

Simplex Trading sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2024, closing a stake of 22 shares — an estimated $15 sold.

Simplex Trading first reported a position in RNLX in Q4 2021 and held it in 8 quarters. The position peaked at $307K in Q4 2021. 26 funds tracked by Wall St. Rank hold RNLX as of Q1 2024.

  • Simplex Trading reported no remaining Renalytix plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 22 Renalytix plc American Depositary Shares shares in Q1 2024, an estimated $15.
  • Simplex Trading first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's Renalytix plc American Depositary Shares position peaked at $307K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.